---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-011465"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:01:11.576573+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics files March 2025 investor presentation; no material new data disclosed

## Summary
- Company furnished a corporate presentation for meetings with institutional investors and analysts.
- Presentation covers corporate overview, pipeline, and portfolio strategy.
- No specific financial guidance, product updates, or business milestones were included in the filing text.
- Presentation available on company's website; not deemed filed under Exchange Act.
- Confidence low due to absence of substantive new information in the excerpt provided.

## SEC filing metadata
- accession: 0001628280-25-011465
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828025011465/0001628280-25-011465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828025011465/aqst-20250310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-011465
- JSON: https://secwatch.observer/filing/0001628280-25-011465.json
- Plain text: https://secwatch.observer/filing/0001628280-25-011465.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.